Erratum to ‘Identification of nephronectin as a new target for IGF1 action’ [Eur J Canc 141 (2020) Pages 115–127] (European Journal of Cancer (2020) 141 (115–127), (S095980492031042X), (10.1016/j.ejca.2020.09.034))

Rive Sarfstein, Lena Lapkina-Gendler, Karthik Nagaraj, Zvi Laron, Haim Werner*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The publisher regrets that Figure 2 was incomplete in the published article. The full Figure 2 is given in the following context. [Figure presented] [Figure presented] The publisher would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)453-454
Number of pages2
JournalEuropean Journal of Cancer
Volume148
DOIs
StatePublished - May 2021

Fingerprint

Dive into the research topics of 'Erratum to ‘Identification of nephronectin as a new target for IGF1 action’ [Eur J Canc 141 (2020) Pages 115–127] (European Journal of Cancer (2020) 141 (115–127), (S095980492031042X), (10.1016/j.ejca.2020.09.034))'. Together they form a unique fingerprint.

Cite this